PT Medikaloka Hermina Tbk (HEAL.JK)
IDR 1420.0
(-1.73%)
IDR 1420.0
(-1.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5784.08 Billion IDR | 18.0% |
| 2022 | 4901.81 Billion IDR | -15.78% |
| 2021 | 5820.12 Billion IDR | 31.8% |
| 2020 | 4416.04 Billion IDR | 21.62% |
| 2019 | 3630.94 Billion IDR | 18.73% |
| 2018 | 3058.09 Billion IDR | 14.18% |
| 2017 | 2678.19 Billion IDR | 19.87% |
| 2016 | 2234.26 Billion IDR | 30.73% |
| 2015 | 1709.02 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1682.27 Billion IDR | 2.71% |
| 2024 Q2 | 1637.84 Billion IDR | -4.02% |
| 2024 Q1 | 1706.41 Billion IDR | 9.79% |
| 2023 Q3 | 1538.42 Billion IDR | 14.91% |
| 2023 Q2 | 1338.85 Billion IDR | -1.02% |
| 2023 Q1 | 1352.59 Billion IDR | 3.2% |
| 2023 FY | 5784.08 Billion IDR | 18.0% |
| 2023 Q4 | 1554.21 Billion IDR | 1.03% |
| 2022 Q1 | 1192.81 Billion IDR | -0.02% |
| 2022 FY | 4901.81 Billion IDR | -15.78% |
| 2022 Q4 | 1310.6 Billion IDR | 3.84% |
| 2022 Q3 | 1262.08 Billion IDR | 11.07% |
| 2022 Q2 | 1136.3 Billion IDR | -4.74% |
| 2021 Q3 | 1528.78 Billion IDR | 1.02% |
| 2021 Q1 | 1584.87 Billion IDR | 3.37% |
| 2021 Q2 | 1513.37 Billion IDR | -4.51% |
| 2021 FY | 5820.12 Billion IDR | 31.8% |
| 2021 Q4 | 1193.09 Billion IDR | -21.96% |
| 2020 Q4 | 1533.23 Billion IDR | 33.25% |
| 2020 Q2 | 748.27 Billion IDR | -23.95% |
| 2020 Q3 | 1150.64 Billion IDR | 53.77% |
| 2020 Q1 | 983.88 Billion IDR | 4.31% |
| 2020 FY | 4416.04 Billion IDR | 21.62% |
| 2019 Q3 | 899.58 Billion IDR | 1.46% |
| 2019 Q1 | 901.53 Billion IDR | 17.11% |
| 2019 FY | 3630.94 Billion IDR | 18.73% |
| 2019 Q4 | 943.22 Billion IDR | 4.85% |
| 2019 Q2 | 886.59 Billion IDR | -1.66% |
| 2018 Q1 | 746.12 Billion IDR | 4.43% |
| 2018 FY | 3058.09 Billion IDR | 14.18% |
| 2018 Q4 | 769.83 Billion IDR | -0.39% |
| 2018 Q3 | 772.85 Billion IDR | 0.46% |
| 2018 Q2 | 769.28 Billion IDR | 3.1% |
| 2017 Q2 | 640.89 Billion IDR | 0.0% |
| 2017 Q1 | 640.89 Billion IDR | 0.0% |
| 2017 Q3 | 681.93 Billion IDR | 6.4% |
| 2017 Q4 | 714.46 Billion IDR | 4.77% |
| 2017 FY | 2678.19 Billion IDR | 19.87% |
| 2016 FY | 2234.26 Billion IDR | 30.73% |
| 2015 FY | 1709.02 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Bundamedik Tbk | 1488.19 Billion IDR | -288.664% |
| PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -2283.413% |
| PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | -35.64% |
| PT Murni Sadar Tbk | 921.91 Billion IDR | -527.4% |
| PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | -214.484% |
| PT Royal Prima Tbk | 265.33 Billion IDR | -2079.902% |
| PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -1449.033% |
| PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | -276.656% |
| PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 48.313% |
| PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | -131.07% |